- Home
- FFIV vs GH Comparison
FFIV vs GH Comparison
Compare FFIV & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FFIV | GH |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Communications Equipment | Medical Specialities |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1B | 22.9B |
| IPO Year | 1999 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FFIV | GH |
|---|---|---|
| Price | $317.57 | $154.62 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 26 |
| Target Price | ★ $444.67 | $200.76 |
| AVG Volume (30 Days) | 1.0M | ★ 2.1M |
| Earning Date | 10-27-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 23.56 | 6.74 |
| EPS | ★ 9.29 | N/A |
| Revenue | ★ $3,088,072,000.00 | $982,021,000.00 |
| Revenue This Year | $8.46 | $39.22 |
| Revenue Next Year | $6.76 | $35.02 |
| P/E Ratio | $34.48 | ★ N/A |
| Revenue Growth | 9.66 | ★ 32.88 |
| 52 Week Low | $223.76 | $74.55 |
| 52 Week High | $483.30 | $191.05 |
Technical Indicators
Market Signals| Indicator | FFIV | GH |
|---|---|---|
| Relative Strength Index (RSI) | 25.92 | 40.63 |
| Support Level | $276.25 | $154.16 |
| Resistance Level | $419.64 | $177.55 |
| Average True Range (ATR) | 17.44 | 10.01 |
| MACD | -5.83 | -2.02 |
| Stochastic Oscillator | 6.34 | 36.50 |
Price Performance
Historical ComparisonAbout FFIV F5 Inc.
F5 is a market leader in the application delivery controller market. The company sells products for security, application performance, and automation. Its three customer verticals are enterprises, service providers, and government entities. Revenue is evenly split between its services business and products business with revenue trending toward products due to software adoption. The Seattle-based firm was incorporated in 1996, and went public in 1999.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.